2 news items
Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
ZVRA
8 May 24
governance objectives, potential revenues from our arimoclomol expanded access program, the potential for royalty and milestone contributions
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
ZVRA
28 Mar 24
coverage for OLPRUVA with commercial and government payors.The Company expects that OLPRUVA's commercial operations and capabilities
- Prev
- 1
- Next